Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Artiva Biotherapeutics, Inc. (ARTV) had Free Cash Flow per Share of $-1.06 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-25.00M |
|
-- |
|
-- |
|
$26.89M |
|
$-26.89M |
|
$1.89M |
|
$-25.00M |
|
$-25.00M |
|
$-25.00M |
|
$-25.00M |
|
$-25.00M |
|
$-25.00M |
|
$-26.89M |
|
$-26.20M |
|
39.41M |
|
39.41M |
|
$-0.63 |
|
$-0.63 |
|
| Balance Sheet Financials | |
$352.28M |
|
$5.67M |
|
$16.36M |
|
$368.63M |
|
$14.58M |
|
-- |
|
$6.55M |
|
$21.13M |
|
$347.50M |
|
$347.50M |
|
$347.50M |
|
48.79M |
|
| Cash Flow Statement Financials | |
$-41.30M |
|
$32.90M |
|
$283.16M |
|
$27.16M |
|
$301.92M |
|
$274.75M |
|
$3.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
24.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-41.96M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.20% |
|
-7.20% |
|
-6.78% |
|
-7.20% |
|
$7.12 |
|
|
Free Cash Flow per Share |
$-1.06 |
$-1.05 |
|